Nomura Holdings
VKTX icon

Nomura Holdings’s Viking Therapeutics VKTX Stock Holding History

Nomura Holdings’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$936K Buy
+24,000
New +$775K ﹤0.01% 1379
2026
Q1 		– Sell
-30,000
Closed -$1.06M – 2146
2025
Q4 		$1.06M Buy
+30,000
New +$1.06M ﹤0.01% 1320
2024
Q4 		– Sell
-4,500
Closed -$285K – 2416
2024
Q3 		$285K Buy
+4,500
New +$264K ﹤0.01% 1350

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Nomura Holdings's VKTX Position: Q2 2026 in Review

Nomura Holdings opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 13,000 shares worth $507K. The stake represents ﹤0.01% of the portfolio and ranks #1510 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in VKTX as recently as Q4 2025.

Nomura Holdings first reported a position in VKTX in Q4 2019 and has held it in 6 quarters since. The position peaked at $1.06M in Q4 2025. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Nomura Holdings held 13,000 shares of Viking Therapeutics worth $507K as of Q2 2026.
  • Viking Therapeutics was a new Nomura Holdings position in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1510 holding.
  • Nomura Holdings first reported a position in Viking Therapeutics in Q4 2019 and has held it in 6 quarters since.
  • Nomura Holdings's Viking Therapeutics position peaked at $1.06M in Q4 2025.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.